In pancreatic cancer, METTL3 modulates the MAPK cascade to increase the resistance of pancreatic cancer cells to chemotherapy and radiotherapy, while knockdown of METTL3 enhances the radiosensitivity of pancreatic cancer cells [39]. This evidence concerns the gene METTL3 and pancreatic neoplasm.